These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7682198

  • 1. Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation.
    Suzuki F, Matsumoto K, Schmitt DA, Pollard RB, Maeda H.
    Int J Immunopharmacol; 1993 Feb; 15(2):175-83. PubMed ID: 7682198
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F.
    Anticancer Res; 1992 Feb; 12(6B):2219-24. PubMed ID: 1295469
    [Abstract] [Full Text] [Related]

  • 3. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F, Pollard RB, Uchimura S, Munakata T, Maeda H.
    Cancer Res; 1990 Jul 01; 50(13):3897-904. PubMed ID: 2141295
    [Abstract] [Full Text] [Related]

  • 4. Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation.
    Oka K, Miyamoto Y, Matsumura Y, Tanaka S, Oda T, Suzuki F, Maeda H.
    Pharm Res; 1990 Aug 01; 7(8):852-5. PubMed ID: 2146602
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
    Suzuki F, Pollard RB, Maeda H.
    Cancer Immunol Immunother; 1989 Aug 01; 30(2):97-104. PubMed ID: 2480846
    [Abstract] [Full Text] [Related]

  • 6. Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F, Munakata T, Maeda H.
    Anticancer Res; 1988 Aug 01; 8(1):97-103. PubMed ID: 2451896
    [Abstract] [Full Text] [Related]

  • 7. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S, Otsuki M.
    Curr Med Chem Anticancer Agents; 2002 Nov 01; 2(6):715-26. PubMed ID: 12678722
    [Abstract] [Full Text] [Related]

  • 8. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K, Konno T, Miyauchi Y, Maeda H.
    Cancer Res; 1987 Feb 01; 47(3):852-5. PubMed ID: 3026619
    [Abstract] [Full Text] [Related]

  • 9. [Recent advances in research on SMANCS].
    Maeda H.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25 Suppl 1():1-9. PubMed ID: 9512680
    [Abstract] [Full Text] [Related]

  • 10. [SMANCS/lipiodol].
    Maeda H.
    Gan To Kagaku Ryoho; 1994 May 01; 21(6):907-13. PubMed ID: 8185354
    [Abstract] [Full Text] [Related]

  • 11. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
    Yamasaki K, Konno T, Miyauchi Y, Maeda H.
    Gan To Kagaku Ryoho; 1987 May 01; 14(5 Pt 1):1224-8. PubMed ID: 3034169
    [Abstract] [Full Text] [Related]

  • 12. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F, Okuno Y, Maeda Y, Maeda H.
    Gan To Kagaku Ryoho; 1987 Dec 01; 14(12):3305-12. PubMed ID: 2961306
    [Abstract] [Full Text] [Related]

  • 13. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.
    Ohtsuka N, Konno T, Miyauchi Y, Maeda H.
    Cancer; 1987 May 01; 59(9):1560-5. PubMed ID: 3030530
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A, Konno T, Kawaguchi T, Miyauchi Y, Maeda H.
    Cancer Res; 1992 Feb 15; 52(4):1013-7. PubMed ID: 1531320
    [Abstract] [Full Text] [Related]

  • 15. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
    Noda S, Konno S, Tanaka J, Yamada M, Yoshitake N.
    Anticancer Res; 1990 Feb 15; 10(3):709-15. PubMed ID: 2164351
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.
    Maeda H, Sawa T, Konno T.
    J Control Release; 2001 Jul 06; 74(1-3):47-61. PubMed ID: 11489482
    [Abstract] [Full Text] [Related]

  • 17. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
    Tsuchiya K, Uchida T, Kobayashi M, Maeda H, Konno T, Yamanaka H.
    Urology; 2000 Apr 06; 55(4):495-500. PubMed ID: 10736490
    [Abstract] [Full Text] [Related]

  • 18. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb 06; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 19. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H.
    Gan To Kagaku Ryoho; 1989 Oct 06; 16(10):3323-31. PubMed ID: 2552930
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M, Konno T, Ohtsuka N, Mizumachi R, Oda T.
    Gan To Kagaku Ryoho; 1989 Jun 06; 16(6):2183-8. PubMed ID: 2544148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.